ENYO Pharma

ENYO Pharma is a biopharmaceutical company that has been granted several patents based on Inserm inventions. The company is developing therapies for the most significant viral infections and is rapidly emerging as a global leader in antiviral drug research and development. ENYO Pharma’s current R&D focus is on human infectious viruses, with the first two programs targeting treatments for severe seasonal influenza and chronic hepatitis B.